Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mind over movement: can imagining actions help stroke survivors recover?

NCT ID NCT07480122

Knowledge-focused Sponsor: Inonu University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well people who have had a stroke can imagine movements (motor imagery) and how that relates to their neglect, arm function, daily activities, and quality of life. Researchers will assess 50 participants using tests and questionnaires. The goal is to better understand these connections to improve future rehabilitation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of stroke patients residing in Malatya province, and the sample comprises patients who have presented to a specialist physician with this complaint, received a stroke diagnosis, and applied to our clinic. Patients who consult a physical medicine and rehabilitation specialist, have no contraindications indicated by the physician, voluntarily agree to participate in the study, and meet the study criteria will be randomly selected.

Ages

30 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals who have experienced hemiplegia after an ischemic stroke, * who actively use their right extremity according to the Edinburgh Hand Preference Questionnaire, * who have right hemisphere involvement, * who are 18 years of age or older, * who have been diagnosed with a stroke at least 1 and at most 6 months ago, * who have middle cerebral artery involvement, * who have a Standardized Mini Mental Test score of 24 or higher, * who are Stage 2b or higher according to Eggers staging, * who can actively control their hand, wrist, and fingers and perform the release reflex, * who wish to participate in the study voluntarily, and * who have given their informed consent will be included in the research. Exclusion Criteria: * Individuals with major neurological, orthopedic, or rheumatological disorders affecting upper extremity function other than stroke (Polyneuropathy, Parkinson's Disease, Multiple Sclerosis, Rheumatoid Arthritis, etc.), * Individuals with upper extremity amputation, * Individuals with uncontrolled arrhythmia, uncontrolled hypertension, or unstable cardiac conditions, * Individuals with active malignancy and receiving related chemo/radiotherapy, * Individuals unable to cooperate due to aphasia or cognitive impairment, * Individuals with visual and hearing problems, * Individuals with communication problems that would hinder the evaluation and/or implementation of the treatment program, * Individuals who are unable to undergo mental assessment, complete the scales, or are illiterate will be excluded from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Daily life activity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

perceptual disorders stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Daily life activity Motor imargery Neglect, hemispatial Quality of life Stroke Upper extremity function

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.